Palliative hypnosis approaches in the symptomatic treatment of amyotrophic lateral sclerosis (ALS)

被引:1
|
作者
Franklin, John E. [1 ,2 ]
机构
[1] Med Univ South Carolina, Charleston, SC USA
[2] Med Univ South Carolina, Dept Vet Affairs, Med Ctr, POB 12728, Charleston, SC 29422 USA
关键词
ALS; amyotrophic lateral sclerosis; hypnosis; palliative; SEVERE CHRONIC DISEASES; OF-LIFE; CLINICAL HYPNOSIS; DIGNITY THERAPY; ANXIETY; CARE; END; DEPRESSION; EXPERIENCE;
D O I
10.1080/00029157.2023.2252875
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a rare, incurable, and ultimately fatal, devastating, progressive degenerative neurologic disease. It causes upheaval in the lives of patients and family caregivers alike. Palliative care can play an important supportive role in the care of patients and families dealing with the devastation of this illness. Clinical hypnosis has demonstrated benefits in treating the symptoms associated with severe chronic illness. There are, however, few studies looking at the benefits of clinical hypnosis in treating the symptom burden of ALS. This article describes palliative care and how it can provide an additional layer of support to seriously ill patients. A brief review of previous studies of hypnosis in the supportive, symptomatic treatment of ALS is provided, followed by a description of a case series of 30 Veterans who received clinical hypnosis and self-hypnosis training as a complementary treatment for the symptoms of ALS. Details of three case histories are included to highlight and discuss specific strategies and emblematic clinical responses. There is evidence that clinical hypnosis can benefit ALS patients and family caregivers struggling with this devastating illness.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
    Becker, Wolfgang
    Gorges, Martin
    Lule, Dorothee
    Pinkhardt, Elmar
    Ludolph, Albert C.
    Kassubek, Jan
    JOURNAL OF EYE MOVEMENT RESEARCH, 2019, 12 (06):
  • [32] Psychiatric Aspects of Amyotrophic Lateral Sclerosis (ALS)
    Norris, Lorenzo
    Que, Guinevere
    Bayat, Elham
    CURRENT PSYCHIATRY REPORTS, 2010, 12 (03) : 239 - 245
  • [33] Amyotrophic lateral sclerosis (ALS) - Patient decongestion
    Tanant, V.
    REANIMATION, 2011, 20 (02): : S510 - S511
  • [34] DNA methylation in amyotrophic lateral sclerosis (ALS)
    Appleby-Mallinder, C.
    Heath, P.
    Highley, R.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 : 20 - 20
  • [35] Cognitive impairment in amyotrophic lateral sclerosis (ALS)
    Mantovan, MC
    Barba, GD
    Smith, P
    Bonometto, P
    Angelini, C
    NEUROLOGY, 2000, 54 (07) : A342 - A342
  • [36] Sporadic and hereditary amyotrophic lateral sclerosis (ALS)
    Ajroud-Driss, Senda
    Siddique, Teepu
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (04): : 679 - 684
  • [37] Nutritional troubles in amyotrophic lateral sclerosis (ALS)
    Marin, Benoit
    Jesus, Pierre
    Preux, Pierre-Marie
    Couratier, Philippe
    Desport, Jean-Claude
    NUTRITION CLINIQUE ET METABOLISME, 2011, 25 (04): : 205 - 216
  • [38] Amyotrophic lateral sclerosis (ALS) in patient with dermatomyositis
    Papastergios, C.
    Chlopicki, B.
    Bergelin-Axelsson, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 292 - 292
  • [39] Diagnostic criteria for amyotrophic lateral sclerosis (ALS)
    Fuglsang-Frederiksen, Anders
    CLINICAL NEUROPHYSIOLOGY, 2008, 119 (03) : 495 - 496
  • [40] Emotional adjustment in amyotrophic lateral sclerosis (ALS)
    Dorothée Lulé
    Sandra Pauli
    Ertan Altintas
    Ulrike Singer
    Thomas Merk
    Ingo Uttner
    Niels Birbaumer
    Albert C. Ludolph
    Journal of Neurology, 2012, 259 : 334 - 341